{
    "Trade/Device Name(s)": [
        "VITROS Immunodiagnostic Products Troponin I ES Reagent Pack",
        "VITROS Immunodiagnostic Products Troponin I ES Calibrators",
        "VITROS Immunodiagnostic Products Troponin I ES Range Verifiers"
    ],
    "Submitter Information": "Ortho-Clinical Diagnostics, Inc.",
    "510(k) Number": "K062838",
    "Predicate Device Reference 510(k) Number(s)": [
        "K974075",
        "K992349"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MMI",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "December 19, 2006",
    "Summary Letter Received Date": "September 26, 2006",
    "Submission Date": "September 21, 2006",
    "Regulation Number(s)": [
        "21CFR862.1215",
        "21CFR862.1150",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Immunoassay Method, Troponin Subunit",
        "Calibrator, multi-analyte mixture",
        "Quality control material, assayed and unassayed"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "cardiac"
    ],
    "Analyte(s)": [
        "Cardiac Troponin I (cTnI)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "VITROS Immunodiagnostic System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescence immunoassay",
        "Solid phase immunoassay"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Range Verifier"
    ],
    "Document Summary": "FDA 510(k) summary for VITROS Immunodiagnostic Products Troponin I ES assay, calibrators, and range verifiers for cardiac Troponin I measurement in serum and plasma.",
    "Indications for Use Summary": "For quantitative measurement of cardiac Troponin I in human serum and plasma (heparin and EDTA) to aid assessment of myocardial damage and risk stratification, including diagnosis of acute myocardial infarction and risk stratification of patients with non-ST-segment elevation acute coronary syndromes.",
    "fda_folder": "Clinical Chemistry"
}